Back to Search Start Over

Early outcomes in patients undergoing transcatheter versus surgical pulmonary valve replacement.

Authors :
Steinberg ZL
Jones TK
Verrier E
Stout KK
Krieger EV
Karamlou T
Source :
Heart (British Cardiac Society) [Heart] 2017 Sep; Vol. 103 (18), pp. 1455-1460. Date of Electronic Publication: 2017 Mar 28.
Publication Year :
2017

Abstract

Objectives: To identify predictors of morbidity and mortality in patients undergoing either transcatheter pulmonary valve replacement (TPVR) or surgical pulmonary valve replacement (SPVR) in an effort to quantify any early benefit of TPVR over SPVR.<br />Methods: Using a risk-adjusted propensity score model, we compare early major morbidity and mortality between patients undergoing SPVR and TPVR at our institution between January 2006 and January 2014.<br />Results: 145 patients in the SPVR cohort and 78 patients in the TPVR cohort were included. Primary pulmonary regurgitation was more common in the SPVR group (76.6% vs 23.1%, p<0.001) and primary pulmonary stenosis was more common in the TPVR group (9.7% vs 44.9%, p< 0.001). In unadjusted analysis, major morbidity and mortality occurred in 11.7% of SPVR patients versus 3.8% of TPVR patients (p=0.04). However, following risk adjustment and inclusion of a propensity score, no significant difference was seen between the two modalities. A larger right ventricular end-diastolic dimension (RVEDVI) was the only preoperative variable associated with the primary end point (OR 1.013/10 mL/m <superscript>2</superscript> increase, p=0.03). Hospital length of stay was significantly longer in patients undergoing SPVR (6.9±1.0 days SPVR vs 1.2±0.3 days TPVR, p<0.0001), with similar hospital costs between groups (mean: US$44 660±5071 SPVR vs US$48 355±1000 TPVR, p=0.7).<br />Conclusions: Following risk adjustment, no significant differences were observed between SPVR and TPVR strategies. TPVR was associated with a shorter hospitalisation; however, total hospitalisation costs were similar between groups.<br />Competing Interests: Competing interests: TKJ: research grant support, consultant and scientific advisory board for Medtronic. The remaining authors have nothing to disclose.<br /> (© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.)

Details

Language :
English
ISSN :
1468-201X
Volume :
103
Issue :
18
Database :
MEDLINE
Journal :
Heart (British Cardiac Society)
Publication Type :
Academic Journal
Accession number :
28351873
Full Text :
https://doi.org/10.1136/heartjnl-2016-310776